Clinical Trials Browser

OTHER × dostarlimab × Thoracic × Clear all

NCT04701307 2025-12-15

Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas

Phase 2 Active not recruiting

EndocrineThoracic

Lung Neoplasms, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT04940637 2023-05-12

UNITO-001

Phase 2 Unknown

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma

NCT03654833 2023-03-14

MiST

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant